Related Experiment Video
Updated: Aug 14, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Body Composition Assessment in Pediatric Cystic Fibrosis in the Highly Effective Modulator Therapy Era-A Pilot Study
Michelle Yavelow1,2, Athanasios Tsalatsanis3, Marisa Couluris4
1Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of South Florida, Tampa, FL 33612, USA.
Insights
Obesity is rising in cystic fibrosis (CF) patients using highly effective modulator therapy (HEMT). This pilot study found no significant link between higher adiposity and lung function in pediatric CF patients, but more research is needed.
Area of Science:
- Pediatric Pulmonology
- Clinical Nutrition
- Biomedical Engineering
Background:
- Obesity prevalence is increasing in cystic fibrosis (CF) patients due to highly effective modulator therapy (HEMT).
- The impact of increased adiposity on lung function in pediatric CF patients (ppwCF) during the HEMT era is not fully understood.
- Body Mass Index (BMI) has limitations in accurately reflecting body composition in CF care.
Purpose of the Study:
- To investigate the relationship between adiposity and pulmonary function in ppwCF.
- To assess the feasibility of Bioelectrical Impedance Analysis (BIA) for body composition measurement in CF care.
- To compare BIA and dual-energy X-ray absorptiometry (DXA) for body fat assessment in ppwCF.
Main Methods:
- A cross-sectional pilot study involving 34 ppwCF aged 5-18 years.
- Measurements included Bioelectrical Impedance Analysis (BIA), dual-energy X-ray absorptiometry (DXA), and spirometry.
- Statistical analyses included correlation, agreement tests, and regression models to examine relationships between body composition and lung function (FEV1% predicted).
Main Results:
- BIA and DXA-derived body fat percentages showed strong correlation and moderate categorical agreement (Cohen's Kappa 0.574).
- Neither BIA nor DXA fat percentage was significantly associated with FEV1% predicted after adjusting for age and sex.
- No statistically significant association was found between adiposity category and reduced lung function.
Conclusions:
- BIA is a feasible method for measuring body fat in ppwCF and correlates well with DXA.
- This pilot study did not find a significant link between higher adiposity and poorer pulmonary function in ppwCF.
- Larger prospective studies are required to confirm these findings and explore longitudinal relationships in the HEMT era.
Abstract:
Background/Objectives: The prevalence of obesity in cystic fibrosis (CF) has increased following the introduction of highly effective modulator therapy (HEMT). However, the impact of increased adiposity on the lung function of pediatric patients with CF (ppwCF) in the era of HEMT remains incompletely understood. Furthermore, while the body mass index (BMI) is the most commonly used nutritional marker in CF care, it has important limitations and may not accurately reflect body composition. Methods: In this cross-sectional pilot study, ppwCF aged 5-18 years completed Bioelectrical Impedance Analysis (BIA) while a subset completed a dual-energy X-ray absorptiometry (DXA) scan and spirometry. Normality was assessed using Shapiro-Wilk tests. Correlations, categorical association, agreement tests, Firth penalized logistic regression, and exploratory linear regression of continuous FEV1% predicted were used to examine relationships among anthropometric measurements, body compositions, and pulmonary function. Results: Thirty-four individuals completed study procedures (19 female (56%); mean age 9.85 (SD 3.58)). BIA and DXA-derived body fat percentages were strongly correlated, and categorical agreement was moderate (Cohen's Kappa 0.574; p-value 0.005). In age and sex-adjusted linear regression, BIA fat percentage (β = -0.23; 95% CI, -1.09 to 0.64; p = 0.595) and DXA fat percentage (β = -0.47; 95% CI, -2.14 to 1.21; p = 0.552) were not significantly associated with FEV1% predicted. Similarly, Firth logistic models showed no statistically significant association between the adiposity category and reduced lung function. Conclusions: BIA-derived body fat measurements correlate with DXA-derived measurements in ppwCF and demonstrate feasibility for use in routine CF clinic visits. This pilot cohort did not show a statistically significant relationship between higher adiposity and poorer pulmonary function. However, the wide confidence intervals indicate substantial uncertainty. Larger prospective studies are needed to evaluate longitudinal relationships between body composition and lung function in the HEMT era.
More Related Videos
07:38Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History